Clinical protocol reviews and ad-hoc regulatory consulting

Ended Awarded Last action

Contract number
0006
Awardee
Awarding agency
Obligated
$76,810

Award facts

Opportunity
  • W81XWH13R0038 Solicitation number
Contract value 61% obligated
$124,996.24 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 3 offers Multiple Award, Fair Opportunity
Pricing
Cost Plus Fixed Fee
Place of performance
Reston, VA 20190, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Change Order 10 · Clinical protocol reviews $0
Other Administrative Action 9 · Incremental funding payment. $5,000
Exercise an Option 8 · Clinical protocol reviews (OY3) $5,463
Change Order 7 · Action: deobligate excess by and OY1 funds. Requirement: clinical protocol reviews and regulatory consulting. -$51,960
Exercise an Option 6 · Clinical protocol reviews (OY3) $12,652
Funding Only Action 5 · Incremental funding (clin 2001) requirement: regulatory support for investigational device exemption (IDE) and investigational new drug (IND) application… $5,000
Exercise an Option 4 · Requirement: regulatory support for investigational device exemption (IDE) and investigational new drug (IND) application determinations (starting OY 2 of 3).… $12,652
Other Administrative Action 3 · Clinical protocol reviews (OY1) $0
Funding Only Action 2 · Clinical protocol reviews (OY1) - incremental funding $25,305
Exercise an Option 1 · Clinical protocol reviews and ad-hoc regulatory consulting (OY1) $12,652
Original award $50,047
Show all 11

About this award

This is a delivery order contract awarded by the Department of the Army Medical Command to Leidos, Inc. The contract is for clinical protocol reviews and ad-hoc regulatory consulting services, and is under the Medical Product Research and Development indefinite delivery, indefinite quantity (IDIQ) contract vehicle. The contract has a potential value of $124,996.24 and is a cost-plus-fixed-fee type contract. There is no set-aside designation for this award. Leidos, Inc. is a global company providing information technology, engineering, and scientific solutions, particularly in the areas of national security, health, and infrastructure. This contract supports the Army Medical Command's mission-critical medical research and development activities.

Quick answers

Who was awarded contract 0006?

0006 was awarded to Leidos, Inc. by Medical Command (Department of the Army) on March 30, 2017.

How much is contract 0006 worth?

The government has obligated $76,810 on 0006. Its current value, with exercised options, is $124,996.

Is contract 0006 an order under another contract?

Yes. 0006 is a delivery order under W81XWH15D0039, an indefinite delivery contract, on Medical Product Research and Development.

Was contract 0006 competed?

The extent of competition for 0006 was full and open competition. The government received 3 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award